The Clavic-Q-RE therapy by RGCC is a cutting-edge immune therapy that combines the power of both innate and adaptive immunity to destroy cancer cells and provide long-term protection against recurrence. This autologous adoptive cellular therapy harnesses the patient’s own immune cells, enhancing their ability to fight cancer through a multi-faceted immune response. Here’s an overview:

How Clavic-Q-RE Works

1. Blood Sample Collection
   • A blood sample is drawn from the patient to isolate and process their immune cells.
2. Immune Cell Activation
   • The therapy activates and enhances specific immune cells, including:
     • Innate immune cells: Macrophages and Natural Killer (NK) cells, which target and destroy cancer cells immediately.
     • Adaptive immune cells: Dendritic cells, T cells, and antibody-producing plasma cells, which provide targeted and long-lasting immunity.
3. Multi-Dimensional Immune Response
   • By combining innate and adaptive immunity, Clavic-Q-RE creates a powerful and sustained attack on cancer cells while building immune memory to prevent recurrence.
4. Reinfusion
   • The activated immune cells are reinfused into the patient via intravenous (IV) administration to target cancer cells in the body.

Administration Schedule

• Delivered as three single-dose IV treatments, given two weeks apart.

Therapeutic Goals

• Eliminate existing cancer cells.
• Develop long-term immunity to protect against cancer recurrence.

Applications of Clavic-Q-RE

1. For Hematologic and Solid Tumors
   • Effective for cancers beyond stage 2B, where a robust immune response is required.
2. Dual Action (Immediate and Long-Term)
   • Targets cancer cells immediately through innate immunity while adaptive immunity builds sustained protection.

Key Benefits of Clavic-Q-RE

1. Comprehensive Immune Activation:
   • Enhances both innate and adaptive immune responses for a more effective attack on cancer cells.
2. Personalized and Targeted:
   • Tailored to the patient’s unique immune system, ensuring precise and effective treatment.
3. Non-Toxic and Non-Genetic:
   • Does not use genotoxic drugs or alter genetic material, minimizing risks and side effects.
4. Long-Term Immunity:
   • Stimulates the immune system to develop memory cells, reducing the likelihood of cancer recurrence.
5. Suitable for Advanced Stages:
   • Effective for cancers beyond stage 2B, providing hope for patients with more advanced disease.

Contraindications

Clavic-Q-RE is not suitable for patients with:

• Active autoimmune diseases or infections.
• High inflammation, cachexia, or conditions compromising immune function.
• Recent or concurrent treatments such as chemotherapy, radiation, or immunosuppressive therapy.
• Pregnancy or children under 18 years old.

Not Suitable For:

• Compartmentalized cancers.
• CNS cancers.

The Clavic-Q-RE therapy is a breakthrough in cancer treatment, offering a comprehensive and personalized approach to immune activation. By combining the strengths of innate and adaptive immunity, it provides immediate cancer-fighting action and long-term protection, empowering patients with advanced cancers to take control of their health.